Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Developing an in vitro model of memory for the study of Alzheimer's disease.

EF 2021-22

Résumé
Alzheimer's disease (AD) is an incurable neurodegenerative disease that is projected to affect 150 million people by 2050. Researchers believe that the memory loss observed in AD is due to overactivity of the brain that ultimately leads to its malfunction. Despite millions of dollars in research funding and what we currently understand about AD, potential treatments often fail in clinical trials. These failures are often attributed to the fact that many treatments use rodents or cells as their modelling system for a human, three-dimensional cerebral disease. Due to the differences between models, treatments will appear effective at the rodent- or cellular-level, but this do not translate to clinical success and can even worsen a patient's memory loss. Thus, the field of neurodegenerative disease is greatly lacking a modeling system that more accurately represents features and symptoms of an adult AD patient's brain. Recent advances in cerebral organoid technology may be the answer to this problem. Cerebral organoids (COs) are mini lab-grown brains that have been observed to capture many aspects of brain development. Notably, COs show coordinated, electrical brain activity similar to preterm infants and AD in cerebral organoids appear to progress and worsen in a similar fashion to real adult patients. Knowing this, COs could potentially be used to understand how an overactive brain can lead to AD and memory loss. By using our lab's optogenetic method to turn on and off specific neurons in the COs, we will be able to manipulate neural activity and better understand how neural activity might be affected when memories are formed, accessed and subsequently forgotten in AD. Understanding this mechanism can have major implications for designing therapies that control the hyperactivity and prevent AD progression. Ultimately, the development of this platform for modeling human memory will have wide-reaching implications for all neurodegenerative diseases.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
457565
Name
Kao Jennifer
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Developing an in vitro model of memory for the study of Alzheimer's disease.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Cerebral Organoids; Engram Formation; Memory; Memory Models
Abstract
Alzheimer's disease (AD) is an incurable neurodegenerative disease that is projected to affect 150 million people by 2050. Researchers believe that the memory loss observed in AD is due to overactivity of the brain that ultimately leads to its malfunction. Despite millions of dollars in research funding and what we currently understand about AD, potential treatments often fail in clinical trials. These failures are often attributed to the fact that many treatments use rodents or cells as their modelling system for a human, three-dimensional cerebral disease. Due to the differences between models, treatments will appear effective at the rodent- or cellular-level, but this do not translate to clinical success and can even worsen a patient's memory loss. Thus, the field of neurodegenerative disease is greatly lacking a modeling system that more accurately represents features and symptoms of an adult AD patient's brain. Recent advances in cerebral organoid technology may be the answer to this problem. Cerebral organoids (COs) are mini lab-grown brains that have been observed to capture many aspects of brain development. Notably, COs show coordinated, electrical brain activity similar to preterm infants and AD in cerebral organoids appear to progress and worsen in a similar fashion to real adult patients. Knowing this, COs could potentially be used to understand how an overactive brain can lead to AD and memory loss. By using our lab's optogenetic method to turn on and off specific neurons in the COs, we will be able to manipulate neural activity and better understand how neural activity might be affected when memories are formed, accessed and subsequently forgotten in AD. Understanding this mechanism can have major implications for designing therapies that control the hyperactivity and prevent AD progression. Ultimately, the development of this platform for modeling human memory will have wide-reaching implications for all neurodegenerative diseases.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kao, Jennifer
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~